Company Overview and News

 
San Miguel units complete share-swap deal

2018-09-20 bworldonline
SAN MIGUEL Food and Beverage, Inc. (SMFB) has completed the share-swap transaction consolidating the traditional units of parent San Miguel Corp. (SMC) under its portfolio.
PSKXF SMCP1 SMGBY SMGBF SMC2B SMC2A SMC SMC2D SMC2C SMC2F SMC2E PHSXY PSE GSMI

 
While we’re squabbling over traffic congestion, Vietnam has launched its own car brand

2018-09-18 bworldonline
I’ve been to Vietnam once — about a decade ago, to be exact. At the time, I was pleased that the Philippines still had a more advanced state of transportation, judging by the Vietnamese’s preferred means of getting around. I’m referring to the motorcycle, which ruled the streets of Ho Chi Minh City during my visit like plunderers rule politics. It was my first time to be in a place where motorbikes far outnumbered cars.
SMGBF SMC2B SMC2A SMC SMC2D SMC2C SMCP1 SMC2F SMC2E SMGBY

5
Questions on TRAIN 2 a.k.a. TRABAHO

2018-09-16 bworldonline
When the inflation rate of 6.4% for August was finally announced by the Philippine Statistics Authority (PSA) last week, there was a storm of fears that lashed stronger than the most powerful typhoon of the season (Signal No. 4), “Ompong” that trashed northern Philippines and rained heavily the whole weekend on the rest of Luzon.
SMCP1 SMGBF GS GLSSP SMC JBK GSC TFG SMGBY GSJ SMC2B SMC2A SMC2D SMC2C SMC2F SMC2E GJS

2
San Miguel Boosted Further By F&B IPO

2018-09-14 seekingalpha - 2
San Miguel (OTCPK:SMGBY) has seen its stock price surge further on details of the IPO for its food and beverage business. The largest company in the Philippines by sales looks set to expand further as it invests in major infrastructure projects. The stock price has seen tremendous appreciation despite other local stocks seeing a downturn. This downturn has been caused by general anxiety about developing markets and protectionist policies from the Trump administration.
PFP PSKXF SMCP1 PF SMPFY PFP2 SMGBY SMGBF SMC2B HRL SMC2A SMC SMC2D SMC2C SMC2F SMC2E PHSXY PSE GSMI SMPFF

 
Dominguez’s choice: Clark takes precedence over SMC’s aerotropolis

2018-09-12 business.inquirer.net
If Finance Secretary Carlos G. Dominguez III has to choose which the government should prioritize, it will be the development of New Clark City over San Miguel Corp.’s (SMC) proposed P735.6-billion “aerotropolis.”
SMGBF SMC2B SMC2A SMC SMC2D SMC2C SMCP1 SMC2F SMC2E SMGBY

 
SMC unit plans to import palay

2018-09-12 bworldonline
THE FOOD AND BEVERAGE unit of diversified conglomerate San Miguel Corp. (SMC) said it plans to import unmilled rice should the government pass a law lifting quantitative restrictions (QR) on the volume of rice imports annually.
SMGBF SMC2B SMC2A SMC SMC2D SMC2C SMCP1 SMC2F SMC2E SMGBY

 
PHL vs Iran in FIBA qualifiers match today

2018-09-12 bworldonline
A NEW-LOOK Team Pilipinas takes the cudgels for the country in the FIBA World Cup Asian Qualifiers, taking on Iran today at the start of the second round of the competition.
SMGBF SMC2B SMC2A SMC SMC2D SMC2C SMCP1 SMC2F SMC2E SMGBY

 
Regulator to look into minority shareholder’s complaint vs SMC

2018-09-11 bworldonline
THE Securities and Exchange Commission (SEC) has formed a special panel to investigate a complaint filed against San Miguel Corp. (SMC) and its subsidiaries for allegedly violating the mandatory tender offer rule prior to the merger of its traditional businesses.
PFP SMCP1 PF SMPFY PFP2 SMGBY SMGBF SMC2B SMC2A SMC SMC2D SMC2C SMC2F SMC2E GSMI SMPFF

 
AirAsia joins consortium for Clark O&M bid

2018-09-10 bworldonline
AIRASIA Group Bhd. is joining a consortium, which includes Indonesian airport operator PT Angkasa Pura, that will make a bid for the operations and management (O&M) contract for Clark International Airport in Pampanga.
SMCP1 MPCIY GMQRY GMRINFRA SMGBY 532754 SMGBF FILIY SMC2B SMC2A SMC SMC2D SMC2C MWP MPI MPCFF SMC2F SMC2E FDC MWIDE

 
Sy, Villar lead Forbes’ richest in PH

2018-09-06 newsinfo.inquirer.net
Some of them have grown wealthier despite slower domestic economic growth, higher inflation and the recent stock market downturn.
SVTMF SMCP1 BDOUY SM SECB BDOUF SMGBF SMIVY SMC MWP SBS SPHXF MWIDE SPHZF GMA7 SMGBY SMPH BDO SMC2B SMC2A SMC2D SMC2C SMC2F SPHXY SYBJF SMC2E GNWKY

 
Razon’s ICTSI cornering biggest stake in busiest domestic port

2018-09-06 business.inquirer.net
Billionaire Enrique Razon Jr.’s International Container Terminal Services Inc. (ICTSI) is increasing its stake in Manila North Harbor Port Inc. to 50 percent—a deal that would make ICTSI the single largest shareholder in the country’s biggest domestic port.
ICT SVTMF PSKXF SMCP1 MPCIY SM ICTEF SMGBY SMGBF SMC2B SMIVY SMC2A SMC SMC2D SMC2C MPI MPCFF SMC2F SMC2E PHSXY PSE

 
Villar breaks into Sy-led 10 richest Filipinos list

2018-09-06 bworldonline
HENRY SY, Sr. remains the country’s wealthiest man for the 11th straight year in Forbes Asia’s “Philippines’ 50 Richest” list, which reflected the economy’s overall volatility as many registered shifts in wealth from 2017.
ICT JGSMY GTCAP GTCXY SVTMF NIKL SMCP1 JGS SM ICTEF SECB SMGBF SMIVY SMC ALGGY SBS AGI JGSHF GMA7 SMGBY NIKAY SMC2B SMC2A SMC2D TECH SMC2C SMC2F SYBJF SMC2E ALGGF GNWKY LTG

 
Ayala Corp. CEO senses ‘growing impatience’ with PHL gridlocks

2018-09-06 bworldonline
PHILIPPINE companies can fund President Rodrigo Duterte’s $170-billion infrastructure push while China’s pledges are taking time, Ayala Corp. executive Jose Rene Almendras said.
SMGBF SMC2B SMC2A SMC SMC2D SMC2C SMCP1 SMC2F SMC2E SMGBY

 
Manny Villar rises to 2nd spot in Forbes’ rich list

2018-09-06 newsinfo.inquirer.net
Businessman Manuel Villar’s net worth is now at $5 billion (P267.3 billion), according to the newest Philippine rich list published by business magazine Forbes, making him the second richest man in the country.
GMA7 SVTMF SMCP1 SM SMGBY SMGBF SMC2B SMIVY SMC2A SMC SMC2D SMC2C SMC2F SMC2E GNWKY

 
Tourism: The new leg of the economy

2018-09-05 bworldonline
OUR Balance of Payment (BoP) deficit is a ticking bomb. In the first semester of the year, the country’s BoP deficit ballooned to US$3.26 billion, nearly five times more than the US$706-million deficit recorded for the same period last year.
C6L SMCP1 AIR SINGY ANZFY SMGBY AIZ SMGBF SMC2B SMC2A SMC SMC2D SMC2C ANZLY SMC2F SMC2E ANZFF SINGF

Related Articles

DMPI: DelMar Pharmaceuticals Analysis and Research Report

1m - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...